Web Based Therapist Tutorial on Prolonged Grief

Status Completed

Clinical Trial Summary

Death of a loved one is a difficult life experience. About 1 in 10 bereaved people are strongly affected by the loss and grieve intensely for a long time. As a result of the COVID-19 pandemic, more people may struggle with grief. The investigators have developed and tested a talk therapy for prolonged grief. The investigators have developed an online grief training for clinicians. The investigators will test if clinicians benefit from the online training and if they find it helpful and engaging. The investigators will recruit 30 mental health professionals as trainees to undergo the training. The mental health professionals will complete questionnaires before and after training to determine how much they learned and how much they liked the training.

Clinical Trial Description

The investigators developed a short-term, manualized Prolonged Grief Disorder Therapy (PGDT), originally known as Complicated Grief Treatment and found it efficacious in three large National Institute of Mental Health (NIMH) sponsored randomized controlled trials. Facilitating access to training in Empirically Based Treatments has been identified as a national priority by both mental health professional organizations and NIMH. One way to help disseminate therapist training on EBT of Prolonged Grief Disorder (PGD) is through the use of new technologies. The investigators recently developed an online therapist training program in PGDT and a patient facing therapist-assisted web-based form of PGDT. The investigators are now looking to evaluate the acceptability and effectiveness of each of these online tools in pilot studies. The tutorial contains 10 modules, each about 20-40 minutes long with information needed for effective delivery of PGDT. Participants will be encouraged to space out the tutorial vs. taking it in a few long sessions, to facilitate knowledge retention. A post-test will be given immediately after completing each module, as testing done closer to when the material was learned also improves retention. Participants will be encouraged to complete the tutorial within 5 weeks (about one hour or two modules per week). Consistent with continuing education guidelines, successful completion will require an overall score of 80% on post-tests. Participants would need to retake the module until a passing score is obtained. Interactive Patient Scenarios will be integrated into the tutorial at strategic points, in order to integrate conceptual and applied knowledge. All participants will be asked to evaluate whether the stated learning goals of each module were met and complete user satisfaction questionnaires on both the technical aspects of the on-line tutorial (using the System Usability Scale), and the clinical content (using the User Satisfaction Questionnaire). Participants will have access to the tutorial indefinitely, in order to provide a resource that they can refer back to as they begin to use these skills with patients. ;

Study Design

Related Conditions & MeSH terms

Prolonged Grief Disorder

Clinical Trial Details

NCT number	NCT05121792
Study type	Interventional
Source	Columbia University
Contact
Status	Completed
Phase	N/A
Start date	October 28, 2021
Completion date	June 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04552717` - My Grief - an App for Parents With Prolonged Grief After Losing a Child to Cancer	N/A
Active, not recruiting	`NCT05026827` - Iyengar Yoga for Prolonged Grief Disorder	N/A
Completed	`NCT05575817` - Web Based Patient Tutorial on Prolonged Grief	N/A
Withdrawn	`NCT01247025` - Prolonged Grief and Suicide Among Veterans	N/A
Recruiting	`NCT04121884` - Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART)	N/A
Completed	`NCT05219760` - LIVIA 2.0 : A RCT Of Two French Internet Intervention For Adults Struggling With Prolonged Grief Symptoms	N/A
Completed	`NCT04409821` - Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care	N/A
Completed	`NCT04505904` - Oxytocin and Approach-avoid in Grief	N/A
Withdrawn	`NCT03568955` - Measurement and Assessment of Prolonged Grief Disorder in Asia
Terminated	`NCT04547985` - Naltrexone Treatment for Prolonged Grief Disorder (PGD)	Phase 4
Recruiting	`NCT05274841` - Systematic Support for Relatives of Palliative Care Patients	N/A
Completed	`NCT01556048` - Pilot Study of Behavioral Activation for Prolonged Grief	Phase 1
Recruiting	`NCT04462146` - An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD)	N/A
Completed	`NCT02283333` - Treatment of Prolonged Grief Disorder in Combat Veterans	N/A
Enrolling by invitation	`NCT06017765` - Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder	N/A
Recruiting	`NCT05365139` - Diagnostic Tools for Identifying Prolonged Grief
Recruiting	`NCT00553956` - A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide	Phase 1
Recruiting	`NCT04694807` - Cognitive Behavioural Therapy for Complicated Grief Reactions in Old Age	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.